Biotechnology company founded in 2007 by scientists including David Sinclair and Nir Barzilai. Based in Menlo Park, California, CohBar develops therapeutics derived from mitochondria-encoded peptides (MDPs). Its pipeline addresses metabolic dysfunction, fibrosis, and immune-related diseases by modulating mitochondrial pathways of aging. (cohbar.com)...